Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (1 trial)
Meningitis (Phase 3)
Meningitis, Bacterial (Phase 3)
Trials (1 total)
Trial APIs (1 total)